Glycoxidation of the bone matrix modulates mineralization

Area of Science:

• Biomaterials Science
• Bone Biology
• Metabolic Diseases

Background:

• Type 2 diabetes (T2D) is linked to increased fracture risk despite normal or high bone mineral density.
• T2D elevates oxidative stress and hyperglycemia, promoting advanced glycation end products (AGEs) and advanced glycoxidation end products (AGOEs) in bone.
• Carboxymethyl-lysine (CML), an AGOE, is implicated in fracture risk and may affect bone mineralization.

Purpose of the Study:

• To investigate the mechanism by which glycoxidation influences bone mineralization.
• To determine how CML accumulation impacts bone quality in a type 2 diabetes context.

Main Methods:

• Human tibial bone sections from various donors were treated in vitro to enhance AGE and CML content.
• Raman spectroscopy, solid-state Nuclear Magnetic Resonance (NMR), and X-ray diffraction were used to analyze mineral growth and structure.
• Nanoindentation assessed mechanical properties like hardness and work energy.

Main Results:

• AGE and CML enhancement increased bone mineralization degree and accelerated mineral maturation.
• CML-enhanced bone showed the most significant increase in mineral growth.
• CML increased collagen and mineral surface electronegativity, leading to higher compressive strain and altered mechanical properties (lower hardness, higher work energy).

Conclusions:

• Glycoxidation, specifically CML accumulation, provides a mechanism linking T2D to altered bone mineralization and impaired bone quality.
• CML directly influences bone matrix mineralization, affecting its structural integrity.
• Developing strategies to target CML accrual is crucial for mitigating fracture risk in type 2 diabetes patients.